About 69% of pediatric patients had discontinued amblyopia therapy during COVID-19 even as their parents reported that adherence was good. Although parents reported good adherence to therapy, a new ...

Massachusetts-based Luminopia landed an FDA De Novo for its virtual reality digital therapeutic focused on helping children improve amblyopia, commonly called lazy eye. The therapy, called Luminopia ...

Crunchyroll, the global brand fueling anime fandom, is now part of an FDA-approved and doctor-prescribed VR treatment for kids with lazy eye. Through a new collaboration with digital health company ...

FDA-cleared CureSight™ therapy now reimbursed by Elevance Health, expanding access to effective digital treatment for lazy eye in children AIRPORT CITY, ISRAEL / ACCESS Newswire / April 21, 2025 / ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted de novo premarket approval for Luminopia One, a digital therapy for children aged 4 to 7 ...

Amblyopia, better known as lazy eye, is the leading cause of vision loss in children and young adults; there’s about 1 million children, and about 4 million adults, who have this condition, and yet ...

Please provide your email address to receive an email when new articles are posted on . NovaSight announced that it is launching CureSight, its digital therapy for amblyopia, to the U.S. market this ...

SAN FRANCISCO, Aug. 27, 2019 (GLOBE NEWSWIRE) -- AmblyoPlay, a home-based vision therapy solution for children and adults with amblyopia (lazy eye), mild strabismus (crossed or turned eye) or ...